UBS Group’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-17,695
| Closed | -$295K | – | 8370 |
|
|
2017
Q3 | $295K | Buy |
17,695
+4,173
| +31% | +$67.9K | ﹤0.01% | 4580 |
|
|
2017
Q2 | $242K | Buy |
13,522
+947
| +8% | +$17.7K | ﹤0.01% | 4634 |
|
|
2017
Q1 | $252K | Buy |
12,575
+8,262
| +192% | +$192K | ﹤0.01% | 4502 |
|
|
2016
Q4 | $108K | Buy |
4,313
+3,108
| +258% | +$73.4K | ﹤0.01% | 5238 |
|
|
2016
Q3 | $28K | Sell |
1,205
-159
| -12% | -$3.74K | ﹤0.01% | 6017 |
|
|
2016
Q2 | $27K | Sell |
1,364
-4,743
| -78% | -$88.5K | ﹤0.01% | 6059 |
|
|
2016
Q1 | $104K | Sell |
6,107
-708
| -10% | -$14.5K | ﹤0.01% | 4954 |
|
|
2015
Q4 | $151K | Buy |
6,815
+5,087
| +294% | +$106K | ﹤0.01% | 4898 |
|
|
2015
Q3 | $29K | Sell |
1,728
-268
| -13% | -$4.17K | ﹤0.01% | 6344 |
|
|
2015
Q2 | $27K | Buy |
+1,996
| New | +$26.5K | ﹤0.01% | 6608 |
|
|
2015
Q1 | – | Sell |
-20,708
| Closed | -$219K | – | 9788 |
|
|
2014
Q4 | $219K | Buy |
+20,708
| New | +$245K | ﹤0.01% | 4966 |
|
UBS Group's OME Position: Q4 2017 in Review
UBS Group sold out of Omega Protein (OME) in Q4 2017, closing a stake of 17,695 shares — an estimated $295K sold.
UBS Group first reported a position in OME in Q4 2014 and held it in 11 quarters. The position peaked at $295K in Q3 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- UBS Group reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- UBS Group sold 17,695 Omega Protein shares in Q4 2017, an estimated $295K.
- UBS Group first reported a position in Omega Protein in Q4 2014 and held it in 11 quarters.
- UBS Group's Omega Protein position peaked at $295K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.